Robert S. Mills, Director at TFF Pharmaceuticals, Inc. (TFFP), sold 700 shares at $20.16 ($14K) on 2021-02-10, disclosed to the SEC on 2021-02-12.
Scheduled sale ($14k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| TFFP | SELL | 2020-12-15 | $665K | — | Filing → |
| TFFP | BUY | 2019-10-29 | $25K | — | Filing → |